Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1979 Jun;307(2):105-13.
doi: 10.1007/BF00498451.

The influence of (+)-propranolol on the inotropic effect of dihydro-ouabain in relation to stimulation frequency

The influence of (+)-propranolol on the inotropic effect of dihydro-ouabain in relation to stimulation frequency

F Ebner et al. Naunyn Schmiedebergs Arch Pharmacol. 1979 Jun.

Abstract

1. The influence of (+)-propranolol, 10(-6) to 4 x 10(-5) mol/l, upon the positive inotropic effect of dihydro-ouabain was studied on guinea-pig papillary muscle. At 1 Hz, negative inotropically effective concentrations of (+)-propranolol decreased the inotropic effectiveness of the glycoside. 2. For equivalent diminution of the basal force of contraction, either by reduction of stimulation frequency or by increasing concentrations of (+)-propranolol, a similar decrease in the inotropic effectiveness of dihydro-ouabain was observed. In contract, reduction of [Ca2+]o had almost no effect on the effectiveness of the glycoside. 3. The inhibitory effect of (+)-propranolol on the inotropic effectiveness of dihydro-ouabain declined with reduction of stimulation frequency. At any stimulation frequency tested, the inhibitory effect of (+)-propranolol was proportional to the effect of a reduction of that particular frequency to the rested-state condition in the absence of (+)-propranolol. 4. The results are consistent with the hypothesis that the inhibition of the excitation-coupled sodium influx by (+)-propranolol is the cause of its inhibiting effect on the effectiveness of dihydro-ouabain.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Pharmacol Exp Ther. 1973 Mar;184(3):599-610 - PubMed
    1. Naunyn Schmiedebergs Arch Pharmacol. 1974;282(2):187-94 - PubMed
    1. J Physiol. 1975 Jul;249(1):27-49 - PubMed
    1. J Pharmacol Exp Ther. 1961 Dec;134:373-89 - PubMed
    1. Arzneimittelforschung. 1974 May;24(5):815-9 - PubMed

LinkOut - more resources